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Cow’s milk, egg, wheat, soy, peanut, and fish account for
about 90% of the food allergies but there are consider-
able differences from one country to another. Milk
allergy is among the best characterized food allergies,
particularly in infants and small children. Only part of
the children with early allergy to cow’s milk grow into
shool-age with milk allergy but those that do often have
severe symptoms and high specific IgE level to milk. In
accordance, attaining tolerance to cow’s milk is asso-
ciated with decreased epitope binding by IgE and a con-
current increase in corresponding epitope binding by
IgG4. Recent data point that analysis of IgE response to
milk components may help in determining those with
higher risk for persistent or more severe milk allergy.
Among wheat allergic patients, co-sensitization to
cow’sm i l ka n dh e n ’s egg is common. Wheat ingestion
may trigger immunoglobulin E (IgE)-mediated immedi-
ate symptoms, including urticaria, angioedema, bron-
chial obstruction, nausea and abdominal pain, or in
severe cases, even systemic anaphylaxis. Delayed reac-
tions include gastrointestinal symptoms and worsen-ing
of atopic dermatitis. In addition to food allergy, wheat
ingestion may cause exercise-induced anaphylaxis, or
celiac disease (CD), and inhalation and handling of
wheat flour aller-gens may lead to respiratory allergy, or
contact urticaria on the skin.
Wheat IgE is commonly found in all ages of atopic
children when whole grains are used as an antigen
either in skin prick tests or serum IgE measurements.
The specificity of this IgE re-sponse in identifying clini-
cal disease, however, is poor. It is of importance to
recognize dis-ease-determining components in the IgE
response. Several studies have shown that sensiti-zation
particularly to omega-5 gliadin is associated with chal-
lenge-proven wheat-allergy. Moreover, recent data imply
that gliadin-positive patients have more likely severe
reactions after wheat ingestion. A well-characterized
severe clinical entity is also wheat-dependent, ex-ercise-
induced anaphylaxis in which sensitization to omega-5
gliadin is a prerequisite.
We have analyzed especially the gliadin-sepcific
responses in wheat allergy. Sensitization to gliadin with
a SPT wheal of ≥5 mm at the time of the diagnostic
challenge was associated with a slower course of recov-
ery from wheat hypersensitivity (p = 0.019), and a SPT
wheal of ≥ 3 mm to gliadin at any time was associated
with the development of asthma. Recently, we examined
IgE response to 22 wheat components in children with
challenge positive wheat allergy and their controls. The
results show that wheat-allergy diagnosis can be
improved considerably by component-based ap-proach.
In the future, wheat IgE diagnosis should include at
least measurement of IgE to gli-adins.
Gluten and its major component, gliadin, is essential
also in the pathogenesis of celiac dis-ease. Gliadin can
b eat a r g e to fb o t hc e l l u l a ra n dh u m o r a li m m u n e
responses. Approximately 90 percent of patients with
celiac disease have the HLA-DQ2 haplotype, explaining
the family-association of the disease but still leaving
open the wide variability in prevalence between dif-fer-
ent Caucasian populations. Both IgA and IgG antibodies
can be seen in CD patients but the most sensitive diag-
nostic work-up is to define tissue transglutaminase
(tTG) transglutami-nase IgA antibodies.
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